Evidence map›Paper›PMID 36896218›Full record

ArticleAdvances in radiation oncology

Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer.

Yoshiyuki Yamamoto, Atsunari Kawashima, Toshitaka Morishima, Toshihiro Uemura, Akinaru Yamamoto, Gaku Yamamichi, Eisuke Tomiyama, Makoto Matsushita, Taigo Kato, Koji Hatano and 2 more

Open access · goldAbstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yoshiyuki YamamotoDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Atsunari KawashimaDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Toshitaka MorishimaCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Toshihiro UemuraDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Akinaru YamamotoDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Gaku YamamichiDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Eisuke TomiyamaDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Makoto MatsushitaDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Taigo KatoDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Koji HatanoDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Isao MiyashiroCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Norio NonomuraDepartment of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
Osaka University · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Radical cystectomy (RC) with neoadjuvant chemotherapy is the most commonly recommended treatment for muscle-invasive bladder cancer (MIBC), yet RC with urinary diversion remains an invasive treatment. Although some patients with MIBC gain good cancer control with radiation therapy (RT), its effectiveness remains under discussion. Therefore, we aimed to reveal the effectiveness of RT compared with RC for MIBC. Methods and Materials: Using cancer registry and administrative data from 31 hospitals in our prefecture, we recruited patients with bladder cancer (BC) initially registered between January 2013 and December 2015. All patients received RC or RT, and none had metastases. Prognostic factors for overall survival (OS) were analyzed by Cox proportional hazards model and log-rank test. Propensity score matching between the RC and RT groups was performed to examine the association of each factor with OS. Results: Among the patients with BC, 241 received RC and 92 received RT. Median ages of the patients receiving RC and RT were 71.0 and 76.5 years, respectively. Five-year OS rates were 44.8% for patients receiving RC and 27.6% for patients receiving RT ( Conclusions: Prognostic analysis with matched characteristics showed that patients with BC receiving RT were not significantly different from those receiving RC. These findings could contribute to proper treatment strategies for MIBC.

Identifiers

PMID36896218
PMCPMC9991535
OpenAlexW4313257049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.